{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:17:09Z","timestamp":1780611429474,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.nmd.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T18:05:45Z","timestamp":1400004345000},"page":"726-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The decreased expression of thioredoxin-1 in brain of mice with experimental autoimmune myasthenia gravis"],"prefix":"10.1016","volume":"24","author":[{"given":"Wenli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2014.05.001_b0005","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1111\/nyas.12013","article-title":"Introduction for myasthenia gravis and related disorders","volume":"1275","author":"Wolfe","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.nmd.2014.05.001_b0010","first-page":"11","article-title":"Pathological findings in the central nervous system in a case of myasthenia gravis","volume":"17","author":"Barrada","year":"1924","journal-title":"Proc R Soc Med (Neurol Sect)"},{"issue":"8033","key":"10.1016\/j.nmd.2014.05.001_b0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(77)91506-9","article-title":"Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis","volume":"2","author":"Lefvert","year":"1977","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-5223(96)70461-0","article-title":"Myasthenia gravis, psychiatric disturbances, idiopathic thrombocytopenic purpura, and lichen planus associated with cervical thymoma","volume":"111","author":"Mineo","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.nmd.2014.05.001_b0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0404.1987.tb05472.x","article-title":"Muscle antibodies in the cerebrospinal fluid from patients with myasthenia gravis","volume":"75","author":"Thorlacius","year":"1987","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.nmd.2014.05.001_b0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1993.00540060055018","article-title":"Coping with myasthenia gravis and implications for psychotherapy","volume":"50","author":"Doering","year":"1993","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0035","first-page":"94","article-title":"Myasthenia gravis. A clinical analysis of the total material from Finland with special reference to endocrinological and neurological disorders","volume":"1","author":"Hokkanen","year":"1969","journal-title":"Ann Clin Res"},{"issue":"1","key":"10.1016\/j.nmd.2014.05.001_b0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/WNL.24.1.72","article-title":"Myasthenia gravis and multiple sclerosis: an unusual combination of diseases","volume":"24","author":"Aita","year":"1974","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2014.05.001_b0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00886878","article-title":"Brain stem auditory evoked potentials reflect central nervous system involvement in myasthenia gravis","volume":"243","author":"Jech","year":"1996","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2014.05.001_b0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1600-0404.1969.tb01266.x","article-title":"Electroencephalographic findings in myasthenia gravis. 180 EEG recordings of 109 patients","volume":"45","author":"Hokkanen","year":"1969","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2014.05.001_b0055","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1017\/sjp.2013.59","article-title":"Facial affect recognition in myasthenia gravis","volume":"16","author":"Lazaro","year":"2013","journal-title":"Span J Psychol"},{"issue":"2A","key":"10.1016\/j.nmd.2014.05.001_b0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1590\/S0004-282X2011000200006","article-title":"Psychiatric disorders in myasthenia gravis","volume":"69","author":"Ybarra","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"10.1016\/j.nmd.2014.05.001_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-200721060-00004","article-title":"Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment","volume":"21","author":"Kulaksizoglu","year":"2007","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0265","first-page":"99","article-title":"Morphologic observations of apoptotic in cerebral cortex of rat experimental myasthenia gravis","volume":"9","author":"Li","year":"2002","journal-title":"Chin J Neuroimmunol Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2014.05.001_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000327727","article-title":"Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis","volume":"19","author":"Peng","year":"2012","journal-title":"Neuroimmunomodulation"},{"issue":"11","key":"10.1016\/j.nmd.2014.05.001_b0080","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","article-title":"Reactive oxygen species, antioxidants, and the mammalian thioredoxin system","volume":"31","author":"Nordberg","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2014.05.001_b0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-2478(94)90038-8","article-title":"Adult T cell leukemia-derived factor\/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide","volume":"42","author":"Nakamura","year":"1994","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.nmd.2014.05.001_b0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/MN:29:3:229","article-title":"Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection","volume":"29","author":"Masutani","year":"2004","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.nmd.2014.05.001_b0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/ars.2006.1513","article-title":"Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"9","author":"Bai","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(00)00199-5","article-title":"Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope","volume":"105","author":"Nakayashiki","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nmd.2005.11.005","article-title":"Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis","volume":"16","author":"Tuzun","year":"2006","journal-title":"Neuromuscul Disord: NMD"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(99)00205-1","article-title":"Does myasthenia gravis affect the brain?","volume":"170","author":"Keesey","year":"1999","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2014.05.001_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-8467(95)00087-9","article-title":"Acquired blepharoptosis","volume":"98","author":"Oosterhuis","year":"1996","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.nmd.2014.05.001_b0120","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s10875-010-9401-x","article-title":"Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems","volume":"30","author":"Vincent","year":"2010","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.nmd.2014.05.001_b0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1358\/dnp.2007.20.9.1162242","article-title":"Antioxidants: a tale of two stories","volume":"20","author":"Pauwels","year":"2007","journal-title":"Drug News Perspect"},{"issue":"29","key":"10.1016\/j.nmd.2014.05.001_b0130","article-title":"The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk\/benefit profile","volume":"7","author":"Brambilla","year":"2008","journal-title":"Nutr J"},{"issue":"6","key":"10.1016\/j.nmd.2014.05.001_b0135","first-page":"598","article-title":"Free radicals, antioxidants, and human disease: where are we now?","volume":"119","author":"Halliwell","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.nmd.2014.05.001_b0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4103\/0253-7613.19072","article-title":"Effect of reactive oxygen species on cholinergic receptor function","volume":"37","author":"Venkatesham","year":"2005","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"10.1016\/j.nmd.2014.05.001_b0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.nmd.2014.05.001_b0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","article-title":"Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury","volume":"9","author":"Janero","year":"1990","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.nmd.2014.05.001_b0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.tips.2005.06.005","article-title":"Thioredoxin: friend or foe in human disease?","volume":"26","author":"Burke-Gaffney","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2014.05.001_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/ars.2007.9.25","article-title":"Thioredoxin and related molecules \u2013 from biology to health and disease","volume":"9","author":"Lillig","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.nmd.2014.05.001_b0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1523\/JNEUROSCI.23-02-00503.2003","article-title":"Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells","volume":"23","author":"Bai","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.nmd.2014.05.001_b0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0891-5849(99)00258-0","article-title":"Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer\u2019s disease brain","volume":"28","author":"Lovell","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nmd.2014.05.001_b0175","doi-asserted-by":"crossref","first-page":"386351","DOI":"10.1155\/2014\/386351","article-title":"Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose tolerance","volume":"2014","author":"Venojarvi","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2014.05.001_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(02)00058-7","article-title":"Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells","volume":"321","author":"Bai","year":"2002","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.nmd.2014.05.001_b0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and regulation of CREB family transcription factors in the nervous system","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nmd.2014.05.001_b0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.nmd.2014.05.001_b0195","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1471-4159.2008.05864.x","article-title":"The CREB\/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death","volume":"108","author":"Lee","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.nmd.2014.05.001_b0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.neuro.21.1.127","article-title":"CREB and memory","volume":"21","author":"Silva","year":"1998","journal-title":"Annu Rev Neurosci"},{"issue":"23","key":"10.1016\/j.nmd.2014.05.001_b0205","doi-asserted-by":"crossref","first-page":"9204","DOI":"10.1523\/JNEUROSCI.21-23-09204.2001","article-title":"Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo","volume":"21","author":"Mabuchi","year":"2001","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.nmd.2014.05.001_b0210","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1523\/JNEUROSCI.4288-04.2005","article-title":"Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.nmd.2014.05.001_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.07080.x","article-title":"CREB: a multifaceted regulator of neuronal plasticity and protection","volume":"116","author":"Sakamoto","year":"2011","journal-title":"J Neurochem"},{"issue":"9","key":"10.1016\/j.nmd.2014.05.001_b0220","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nri2359","article-title":"The endoplasmic reticulum stress response in immunity and autoimmunity","volume":"8","author":"Todd","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.nmd.2014.05.001_b0225","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/cdd.2008.81","article-title":"The unfolded protein response regulator GRP78\/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells","volume":"15","author":"Li","year":"2008","journal-title":"Cell Death Differ"},{"issue":"6765","key":"10.1016\/j.nmd.2014.05.001_b0230","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/47513","article-title":"Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta","volume":"403","author":"Nakagawa","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nmd.2014.05.001_b0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","article-title":"Roles of CHOP\/GADD153 in endoplasmic reticulum stress","volume":"11","author":"Oyadomari","year":"2004","journal-title":"Cell Death Differ"},{"issue":"5266","key":"10.1016\/j.nmd.2014.05.001_b0240","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.272.5266.1347","article-title":"Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase","volume":"272","author":"Wang","year":"1996","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.nmd.2014.05.001_b0245","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1093\/nar\/28.24.4987","article-title":"CHOP gene expression in response to endoplasmic-reticular stress requires NFY interaction with different domains of a conserved DNA-binding element","volume":"28","author":"Ubeda","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.nmd.2014.05.001_b0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1172\/JCI0214550","article-title":"Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes","volume":"109","author":"Oyadomari","year":"2002","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.nmd.2014.05.001_b0255","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/cdd.2012.67","article-title":"C\/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in beta-cells","volume":"19","author":"Allagnat","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.nmd.2014.05.001_b0260","first-page":"10","article-title":"The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease","volume":"67C","author":"Zeng","year":"2013","journal-title":"Free Radic Biol Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896614001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896614001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:02:54Z","timestamp":1760774574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896614001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0960896614001278"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2014.05.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The decreased expression of thioredoxin-1 in brain of mice with experimental autoimmune myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}